Work & Life

Menopause for LGBTQ+ Women

Creator: Dr Nadira Awal
Published: 2026-01-15

Inclusive, respectful menopause care for lesbian, bisexual and queer women.

By Dr Nadira AwalBMS Specialist3 min readMedically reviewed 9 July 2026

Two mugs and softly folded rainbow-toned fabric on a kitchen table

Everyone deserves informed, judgment-free menopause care. This guide covers common gaps in generic advice and how a specialist can tailor support.

Menopause care should fit the person in front of you — their body, their identity, their relationships and their history. LGBTQ+ women, trans men and non-binary people who menstruate have often had a rougher time getting evidence-based menopause care: assumptions get in the way of good history-taking, and clinicians unfamiliar with gender-affirming hormones sometimes hesitate to prescribe or adjust HRT confidently. As a BMS specialist I take the same evidence-based approach — but with language, examination and shared decision-making that fits you.

What genuinely good, inclusive care looks like

A proper history without assumptions about your partner's sex, your sexual practice or your reproductive plans.
Language and pronouns confirmed at the start and used consistently in notes and letters.
A clear conversation about which body parts are still present — uterus, ovaries, breasts — because that drives endometrial protection, cancer screening and HRT choices.
The full range of body-identical HRT preparations offered on merit, not on assumptions about identity.
Awareness of how existing gender-affirming hormones interact with menopause treatment.

For lesbian and bisexual women

The physiology of menopause is the same regardless of sexual orientation — but the healthcare experience often isn't.
Contraception is still relevant in perimenopause for anyone at risk of pregnancy (e.g. previous partners, sperm exposure) — worth a direct conversation.
Cervical screening and breast screening remain relevant — uptake in lesbian and bisexual women is lower than average, largely because of past poor experiences.
Vaginal atrophy affects sex with any partner — vaginal oestrogen is effective and safe.
Fertility considerations (donor sperm, IVF, known donors) may still be active into perimenopause — discuss timing openly.

For trans men and non-binary people with a uterus

Ovaries still produce oestradiol until menopause even during testosterone therapy — perimenopausal symptoms can and do occur.
If a uterus is present, endometrial protection is essential when adding oestradiol as HRT.
Testosterone dose may need review as ovarian function declines; some symptoms improve, others emerge.
Cervical screening remains relevant if a cervix is present — this can be done sensitively with time, small speculum and topical oestrogen if needed.
Chest reconstruction does not remove all breast tissue — breast awareness and screening (where indicated) still apply.

For trans women on gender-affirming oestrogen

You do not have a menopause in the ovarian sense, but hormone regimens still need monitoring — bone density, cardiovascular risk, VTE risk, prolactin, and breast health.
Oestradiol levels should be interpreted in the context of goals and safety, not just numbers.
Discuss long-term regimen with a clinician familiar with gender-affirming care — this is a specialist area.
Bone density scans are important, especially after gonadectomy or on lower doses.

What to ask a new clinician

'What experience do you have working with LGBTQ+ patients on menopause and HRT?' — a fair, direct question.
'Can you confirm my name and pronouns are in the notes and letters?' — small step, big difference.
'How will you talk about my body in this consultation?' — you can set the language you're comfortable with.
'Will you write to my GP in a way that respects my identity?' — worth flagging before letters go out.

UK support and resources

Switchboard LGBT+ helpline (0300 330 0630) — inclusive support and signposting.
LGBT Foundation — health information and peer support.
cliniQ — trans-led sexual health and wellbeing service.
GALOP — support for LGBTQ+ people experiencing abuse or discrimination.

Key takeaway

Inclusive menopause care is not a niche subspecialty — it is simply good, evidence-based care delivered with respect.

How Dr Awal approaches this in clinic

Every consultation starts with your full story — symptoms, cycle, medical history, family history and what you've already tried. From there we look at whether hormonal treatment, non-hormonal options, lifestyle changes or a combination will give you the best result, and we tailor the plan to your age, risk factors and preferences.

A detailed 60 minute first appointment — no rushed 10-minute slots.
Evidence-based recommendations aligned with NICE NG23 and BMS guidance.
Body-identical HRT considered first-line where appropriate.
Shared-care letters sent to your NHS GP so treatment can continue affordably.
Follow-up at 3 months to fine-tune your regimen and address side effects.
Ongoing annual reviews so your plan evolves with you.

Common questions we hear about this

Do I need to be at a certain age to be seen?

No. We see women in early perimenopause (often late 30s and 40s), through post-menopause and beyond. Age alone doesn't decide whether treatment is right — symptoms, health history and goals do.

Will my GP continue the prescription?

In most cases yes. After your consultation we send a detailed shared-care letter with the diagnosis, treatment plan and rationale so your NHS GP can prescribe on the NHS. Not every practice accepts shared care — we'll discuss this in your appointment.

What if I've tried HRT before and it didn't suit me?

Very common — often the type, dose or route wasn't right rather than HRT itself. We review what you've tried, why it didn't work, and adjust accordingly. Many women who thought HRT wasn't for them do well on a different preparation.

How long will I need to stay on treatment?

There is no set upper time limit for HRT. Current BMS and NICE guidance supports continuing HRT for as long as the benefits outweigh the risks for you personally. We review this together every year so you stay in control of the decision.

Where do you see patients?

All consultations at Pause and Co Healthcare are conducted securely via video, allowing us to support patients anywhere in the UK. Prescriptions and shared care arrangements are managed in the same way, regardless of your location.

About the author

Dr Nadira Awal is a British Menopause Society Advanced Menopause Specialist with 15+ years' NHS and private experience. She holds the BMS Advanced Certificate in Menopause Care, sits on the BMS Programme Planning Group, and advises the UK Government Menopause Strategy Group. Read her full profile.

Sources & further reading

General information only — not a substitute for personalised medical advice. Always speak to your GP or a menopause specialist about your own situation.

Talk it through